Healthy Participants Ages 18 to 45 Needed for Investigational Shigella Vaccine Study
November 29, 2021
We are evaluating the effectiveness of an investigational shigella vaccine.
What's involved in being a participant?
- The research involves up to eight or nine outpatient visits, including a screening session and two vaccinations over eight months (plus up to two months for screening).
- Participants must never have had shigella infection or a shigella vaccine.
- Participants may also have a 12-day inpatient stay. During the inpatient stay, participants will be “challenged” with live shigella.
- The shigella challenge involves exposure to the shigella bacteria to evaluate whether or not the vaccine is effective in preventing shigella infection.
Participants will be compensated $3,150 to $7,350.
Ready to get started?